Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Amanda LS Lang"'
Publikováno v:
SAGE Open Medical Case Reports, Vol 8 (2020)
We present a case of milker’s nodules in a 41-year-old rancher from Saskatchewan, Canada, with secondary complications consisting of papular erythema and lymphadenopathy.
Externí odkaz:
https://doaj.org/article/b8d24ec3d4b64c899360de54e6fb208e
Autor:
Karen Green, Irene Martin, Mark Loeb, Jason LeBlanc, May ElSherif, Lingyun Ye, Donna MacKinnon-Cameron, Ardith Ambrose, Todd F Hatchette, Amanda LS Lang, Hayley D Gillis, Walter H Demczuk, Craig LaFerriere, Melissa K Andrew, Guy Boivin, William Bowie, Jennie Johnstone, Anne McCarthy, Allison McGeer, Makeda Semret, Sylvie Trottier, Louis Valiquette, Duncan Webster, Shelly A McNeil
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Background In Canada, 13-valent pneumococcal conjugate vaccine (PCV13) is recommended in childhood, in individuals at high risk of invasive pneumococcal disease (IPD) and in healthy adults aged ≥65 years for protection against vaccine-type IPD and
Externí odkaz:
https://doaj.org/article/89c02dc9740f4a5a8037a9d0017c7561
Publikováno v:
SAGE Open Medical Case Reports, Vol 8 (2020)
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports
We present a case of milker’s nodules in a 41-year-old rancher from Saskatchewan, Canada, with secondary complications consisting of papular erythema and lymphadenopathy.
Autor:
Sylvie Trottier, Melissa K. Andrew, Makeda Semret, Amanda Ls Lang, Irene Martin, Shelly A. McNeil, Louis Valiquette, Jennie Johnstone, Ardith Ambrose, Karen Green, Walter Demczuk, Todd F. Hatchette, Mark Loeb, Donna MacKinnon-Cameron, Anne E. McCarthy, Jason J. LeBlanc, William R. Bowie, Lingyun Ye, May Elsherif, Allison McGeer, Hayley D. Gillis, Duncan Webster, Craig Laferriere, Guy Boivin
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BMJ Open Respiratory Research
BMJ Open Respiratory Research
BackgroundIn Canada, 13-valent pneumococcal conjugate vaccine (PCV13) is recommended in childhood, in individuals at high risk of invasive pneumococcal disease (IPD) and in healthy adults aged ≥65 years for protection against vaccine-type IPD and p